Xinhua News Agency, May 13, mRNA COVID-19 Vaccine of Shijiazhuang Group mRNA COVID-19 Vaccine was vaccinated at the vaccination clinic of Taoyuan Community Health Service Center in Shijiazhuang City for the first time nationwide. This vaccine is the first mRNA COVID-19 vaccine in China. According to the recommendation of the vaccine research and development special class of the scientific research group of the joint prevention and control mechanism of the State Council, according to the relevant responsible person of the Stone Pharmaceutical Group, the novel coronavirus mRNA vaccine of the Stone Pharmaceutical Group covers the core mutation site of O'Micron and has a better cross-protection effect on O'Micron virus strains. The key raw materials and excipients used in mRNA vaccine of Stone Pharmaceutical Group, such as core lipids and hat analogues for mRNAs, are produced by Stone Pharmaceutical Group, and other excipients are domestically produced. (Hebei Daily)